TELK is what we call a "pump and dump," much like Enron.
Instead of reading the BS posts, read the financials:
And Balance Sheet:
They have lost $2M consistently each quarter for the past 3 years.
Going into 2011, they had $18M.
Going into 2012, they had $8M.
Going into 2013, they had $2M (before posting 4th quarter losses).
Once they post 4th quarter losses of $2M yet again, they will file for bankruptcy.
You are buying a bankrupt company at $3 / share. TELK has not produced any new products for the past 3 years and they are not ready to release anything for the next year.
The book value of this company before 4th quarter earnings is 0.75.
After earnings, 0.00.
Sentiment: Strong Sell
As of today. Company has $2.38 per share in CASH and NO DEBT. It now has an
orphan status for its drug. and only 2.25 mil shares. Even if they make just $2 mil
per year off the drug it translates to $1.00 EPS.... assign a 8 pe and u get a $8 stock
assign a 15 pe and we have a $15 stock. TELK was at $7++ just few months ago...